Sinopharm Group Co Ltd (SHTDY)
14.24
+0.55
(+3.99%)
USD |
OTCM |
May 13, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 8.887B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -12.51% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | 0.8447 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.5743 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 64.46% |
Profile
| Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers. |
| URL | http://www.sinopharmgroup.com.cn |
| Investor Relations URL | http://ir.sinopharmgroup.com.cn/ |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Aug. 28, 2024 (est.) |
| Last Earnings Release | Oct. 30, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 15, 2023 |
Ratings
Profile
| Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers. |
| URL | http://www.sinopharmgroup.com.cn |
| Investor Relations URL | http://ir.sinopharmgroup.com.cn/ |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Aug. 28, 2024 (est.) |
| Last Earnings Release | Oct. 30, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 15, 2023 |